Maternal Cannabis Use Linked to Adverse Pregnancy Outcomes
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 12, 2023 -- Maternal cannabis use is associated with adverse pregnancy outcomes known to be related to placental dysfunction, according to a study published in the Dec. 12 issue of the Journal of the American Medical Association.
Torri D. Metz, M.D., from the University of Utah Health in Salt Lake City, and colleagues examined the association between maternal cannabis use and adverse pregnancy outcomes known to be related to placental function in an ancillary analysis of nulliparous individuals treated at eight U.S. medical centers. Participants were recruited from 2010 through 2013; 9,257 were eligible for the analysis.
The researchers found that 610 participants (6.6 percent) had cannabis use: 32.4 and 67.6 percent had exposure only during the first trimester and ongoing exposure beyond the first trimester, respectively. In the propensity score-weighted analyses after adjustment for sociodemographic characteristics, body mass index, medical comorbidities, and active nicotine use ascertained via urine cotinine assays, cannabis exposure was associated with the primary composite outcome: small-for-gestational-age birth, medically indicated preterm birth, stillbirth, or hypertensive disorders of pregnancy (25.9 versus 17.4 percent; adjusted relative risk, 1.29). Cannabis use during the first trimester only was not associated with the primary composite outcome, but ongoing cannabis use was associated with the primary composite outcome (adjusted relative risk, 1.32) in a three-category cannabis exposure model.
"Cannabis use is not safe," coauthor Robert M. Silver, M.D., also from the University of Utah Health, said in a statement. "It increases the risk of pregnancy complications. If possible, you shouldn't use cannabis during pregnancy."
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-13 22:15
Read more
- Integrative CBT for Prolonged Grief Beats Present-Centered Therapy
- Too Many Meds: 'Polypharmacy' Can Really Harm Alzheimer's Patients
- FDA Approves Danziten (nilotinib) Tablets, the First and Only Nilotinib With No Mealtime Restrictions
- Fatty Liver Disease Now Affects 4 in 10 U.S. Adults
- Nursing-Sensitive Quality Indicators Negatively Impacted by Pandemic
- RSV Vaccination Prevents Associated Hospitalization, Emergency Encounters
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions